ARDX ARDELYX INC
2026Q1 · CUSIP 039697107 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
237
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
134
Δ whales
+8
Inst. holding value
$1.0B
New positions
50
Closed positions
40
Price momentum (1Q)
-9.6%
Put / Call
4/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 19% | +14.0% | +6.1% |
| 2024Q1 | Top 11% | -23.3% | -36.4% |
| 2023Q2 | Top 12% | +7.0% | +150.0% |
| 2023Q1 | Top 6% | -10.7% | -1.5% |
| 2022Q4 | Top 18% | +20.9% | +19.9% |
| 2020Q2 | Top 13% | -1.9% | +21.8% |
| 2019Q4 | Top 18% | -3.3% | -25.8% |
| 2019Q3 | Top 19% | +36.9% | +26.3% |
| 2018Q2 | Top 16% | -33.7% | -36.3% |
Options Sentiment
Put holders
4
QoQ: 0
Call holders
8
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.24
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+18.2%
Net margin
-13.6%
ROE
-39.1%
Debt ratio
70.5%
FCF (TTM)
-$37M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.